{
  "created_at": "Tue Oct 05 14:47:47 +0000 2021",
  "id_str": "1445392109960318983",
  "full_text": "Johnson &amp; Johnson has asked U.S. health regulators to authorize a booster dose for its Covid-19 vaccine, citing studies showing it improved protection among adults who previously received a single shot https://t.co/pumRSfxREc",
  "display_text_range": [
    0,
    229
  ],
  "entities": {
    "hashtags": [],
    "symbols": [],
    "user_mentions": [],
    "urls": [
      {
        "url": "https://t.co/pumRSfxREc",
        "expanded_url": "https://on.wsj.com/2YnchpW",
        "display_url": "on.wsj.com/2YnchpW",
        "indices": [
          206,
          229
        ]
      }
    ]
  },
  "user": {
    "name": "The Wall Street Journal",
    "screen_name": "WSJ",
    "profile_image_url_https": "https://pbs.twimg.com/profile_images/971415515754266624/zCX0q9d5_normal.jpg"
  },
  "retweet_count": 19,
  "favorite_count": 126,
  "possibly_sensitive": false,
  "original_created_at": "Tue Oct 05 14:15:07 +0000 2021",
  "localize": [
    {
      "locale": "ja",
      "full_text": "ジョンソン・アンド・ジョンソン社は、Covid-19ワクチンの追加投与を承認するよう米国の保健当局に要請しました。その理由として、過去に単回接種を受けた成人の予防効果が向上したという研究結果を挙げています。https://t.co/pumRSfxREc"
    },
    {
      "locale": "zh",
      "full_text": "强生公司已要求美国卫生监管机构批准其Covid-19疫苗的加强剂量，理由是研究表明它提高了之前接受单次注射的成年人的保护能力 https://t.co/pumRSfxREc。"
    },
    {
      "locale": "zh-Hant",
      "full_text": "強生公司已要求美國衛生監管機構批准其Covid-19疫苗的加強劑量，理由是研究表明它提高了之前接受單次注射的成年人的保護能力 https://t.co/pumRSfxREc。"
    }
  ]
}